Improvement of chronic congestive heart-failure by oral captopril

Détails

ID Serval
serval:BIB_25F71F2ED1CA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Improvement of chronic congestive heart-failure by oral captopril
Périodique
Lancet
Auteur⸱e⸱s
Turini  G. A., Brunner  H. R., Gribic M., Waeber B., Gavras H.
ISSN
0140-6736
Statut éditorial
Publié
Date de publication
1979
Peer-reviewed
Oui
Volume
1
Numéro
8128
Pages
1213-5
Langue
anglais
Notes
Journal Article
Résumé
Catopril, an inhibitor of angiotensin converting enzyme, was given orally during cardiac catheterisation to 6 normotensive patients with refractory congestive heart-failure. 60--180 minutes after administration of 25 mg captopril, arterial pressure fell by 25%, cardiac index rose by 38%, and left-ventricular pressure and right-atrial pressure fell by 25% and 40% respectively. Plasma-renin activity rose while plasma noradrenaline and aldosterone fell. These data suggest that, in the short term, captopril can reduce both preload and afterload, and improve cardiac function, in refractory congestive heart-failure.
Mots-clé
Administration, OralAdultAldosterone Antagonists*Angiotensin-Converting Enzyme InhibitorsBlood Pressure/drug effectsCardiac Output/drug effectsChronic DiseaseDrug EvaluationHeart Failure/*drug therapy/physiopathologyHumansMaleMiddle AgedNorepinephrine/antagonists & inhibitorsProline/administration & dosage/*analogs & derivativesRenin/bloodVascular Resistance/drug effects
Pubmed
Web of science
Création de la notice
04/03/2009 16:04
Dernière modification de la notice
20/08/2019 14:04
Données d'usage